🚨 Midfielder WANTS Man Utd move, Chelsea deals progressing, Arsenal now VERY close to signing, Haaland scores again, & more
🚨 Midfielder WANTS Man Utd move, Chelsea deals progressing, Arsenal now VERY close to signing, Haaland scores again, & more
Can Man Utd make a breakthrough with this midfielder signing? Plus news clips as Haaland helps City beat Chelsea and Eze's sublime strike is bizarrely ruled out...
Happy Monday everyone and welcome to the latest Daily Briefing - all today’s essential football headlines in one place, delivered ad-free and straight to your inbox. Thanks for reading, and hope you enjoy!
Today’s top stories:
Ask Fabrizio Romano anything (before 1pm)!
Manuel Ugarte wants Manchester United move
Plus more from Arsenal, Chelsea & Man City
Ajax
Ajax have booked a medical for Daniele Rugani as the Italian centre-back is set to join on loan from Juventus.
Arsenal
Mikel Merino is expected to become a new Arsenal player very soon - they’re working on the final details of this deal.
Mikel Arteta with a huge compliment for Bukayo Saka: “With good players it’s like that. With Messi I know he’s gonna come here and put the ball there, but he does it all the time. You can’t stop him. That’s the quality of the players.”
Aston Villa
20-year-old talent Lamare Bogarde has signed a new contract at Aston Villa today as part of the club’s long term project. Nottingham Forest had a bid rejected for Bogarde in June and he’s now going to sign a new deal at Villa Park.
Atalanta
Teun Koopmeiners and Ademola Lookman are out of Atalanta’s squad for their opening Serie A game. Juventus keep waiting for Koopmeiners after making a €52m plus €7m add-ons bid. Meanwhile, Paris Saint-Germain are among the clubs attentive to Lookman after interest from Saudi.
Lazar Samardzic completes main part of medical tests as Atalanta player with €20m plus €5m add-ons deal closed with Udinese. Atalanta have also booked a medical for Wesley, the Brazilian right-back from Flamengo.
Nico Gonzalez to Juventus latest - could Atalanta hijack the deal? Matteo Moretto takes a look in his latest exclusive column.
Keep reading with a 7-day free trial
Subscribe to the Daily Briefing to keep reading this post and get 7 days of free access to the full post archives.